ZYBT earnings date and last-quarter result: P/E -6.27. Updated 2026-07-23.
Zhengye Biotechnology Holding (ZYBT) Research Hub
Zhengye Biotechnology Holding (ZYBT) trades on NASDAQ, CN in the Healthcare (Drug Manufacturers - Specialty & Generic) sector. As of 2026-10-26, shares last closed at 1.42 USD (-5.33%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -6.27, market cap 0.07B. This hub links to the full technical, earnings and options research available for ZYBT.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Drug Manufacturers - Specialty & Generic) |
|---|---|
| Exchange | NASDAQ, CN |
| Last close | 1.42 USD (-5.33%) |
| 52-week range | 0.616 USD – 8.01 USD |
| Trend regime | Range |
| 14-day RSI | 61.8 (Bullish) |
| Trailing P/E | -6.27 |
| Market cap | 0.07B |
| Dividend yield | 0.00% |
Available research for ZYBT
Covered Call on ZYBT: how it works, illustrative setup around the real 1.42 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on ZYBT: how it works, illustrative setup around the real 1.42 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on ZYBT: how it works, illustrative setup around the real 1.42 USD price, max profit/loss, breakeven and when to use it. Educational.
ZYBT technical analysis: range, last 1.42 USD, RSI 61.8, 52w range 0.616 USD–8.01 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is ZYBT in?
Zhengye Biotechnology Holding (ZYBT) is classified under Healthcare (Drug Manufacturers - Specialty & Generic), listed on NASDAQ, CN.
Is ZYBT in an uptrend or downtrend?
As of 2026-10-26, ZYBT is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is ZYBT's trailing P/E ratio?
ZYBT's trailing P/E is -6.27, with a market cap of 0.07B. See the earnings research page for full valuation detail.